"The familiar taste of poison": a qualitative study of multi-level motivations for stimulant use in sexual minority men living in South Florida.

Leah Davis-Ewart, Ji-Young Lee, Michael Viamonte, Jos�� Colon-Burgos, Audrey Harkness, Mariano Kanamori, Dustin T Duncan, Susanne Doblecki-Lewis, Adam W Carrico, Christian Grov
Author Information
  1. Leah Davis-Ewart: Miller School of Medicine, University of Miami, Miami, FL, USA.
  2. Ji-Young Lee: Department of Mental Health Law and Policy, University of South Florida, Tampa, FL, USA.
  3. Michael Viamonte: Miller School of Medicine, University of Miami, Miami, FL, USA.
  4. Jos�� Colon-Burgos: Robert Stempel School of Public Health and Social Work, Florida International University, Miami, FL, USA.
  5. Audrey Harkness: School of Nursing and Health Studies, University of Miami, Miami, FL, USA.
  6. Mariano Kanamori: Miller School of Medicine, University of Miami, Miami, FL, USA.
  7. Dustin T Duncan: Mailman School of Public Health, Columbia University, New York, NY, USA.
  8. Susanne Doblecki-Lewis: Miller School of Medicine, University of Miami, Miami, FL, USA.
  9. Adam W Carrico: Miller School of Medicine, University of Miami, Miami, FL, USA.
  10. Christian Grov: Graduate School of Public Health and Health Policy, City University of New York, 55 West 125th Street, Office 812, New York, NY, 10027, USA. christian.grov@sph.cuny.edu.

Abstract

BACKGROUND: In the US, stimulant use is associated with a 3-6 times greater rate of HIV seroconversion in sexual minority men (SMM) than in those who do not use stimulants. Annually, 1 in 3 SMM who HIV seroconvert will be persistent methamphetamine (meth) users. The primary objective of this qualitative study was to explore experiences of stimulant use in SMM living in South Florida, a high priority region for the Ending the HIV Epidemic initiative.
METHODS: The sample included 25 SMM who use stimulants, recruited via targeted ads on social networking apps. Participants completed one-on-one semi-structured qualitative interviews, conducted from July 2019 through February 2020. A general inductive approach was used to identify themes relating to experiences, motivations, and overall relationship with stimulant use.
RESULTS: Mean age of participants was 38.8, ranging from 20 to 61 years old. Participants were 44% White, 36% Latino, 16% Black and 4% Asian. Most participants were born in the US, self-identified as gay, and preferred meth as their stimulant of choice. Themes included: (1) stimulants as cognitive enhancements for focus or task completion, including transitioning to meth after first using prescription psychostimulants; (2) unique South Florida environment where participants could be open regarding their sexual minority status while also being influential on their stimulant use; (3) stimulant use as both stigmatizing and a coping mechanism for stigma. Participants anticipated stigma by family and potential sexual partners due to their stimulant use. They also reported using stimulants to cope with feelings of stigma due to their minoritized identities.
CONCLUSION: This study is among the first to characterize motivations for stimulant use in SMM living in South Florida. Results highlight both the risk and protective factors of the South Florida environment, psychostimulant misuse as a risk for meth initiation, and the role of anticipated stigma on stimulant use in SMM. Understanding stimulant use motivations can help to shape intervention development. This includes developing interventions that address individual, interpersonal, and cultural factors that drive stimulant use and increase risk of HIV acquisition. Trial registration NCT04205487.

Keywords

Associated Data

ClinicalTrials.gov | NCT04205487

References

  1. J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):485-90 [PMID: 18077839]
  2. Subst Use Misuse. 2013 Dec;48(14):1541-52 [PMID: 23848380]
  3. PLoS One. 2022 Mar 18;17(3):e0265480 [PMID: 35303025]
  4. Open Forum Infect Dis. 2018 May 02;5(6):ofy097 [PMID: 29977957]
  5. AIDS Behav. 2005 Mar;9(1):63-72 [PMID: 15812614]
  6. Addict Behav. 2021 Jun;117:106831 [PMID: 33588290]
  7. J Acquir Immune Defic Syndr. 2007 May 1;45(1):85-92 [PMID: 17325605]
  8. AIDS Behav. 2021 May;25(5):1454-1463 [PMID: 32737816]
  9. J Psychiatr Res. 2016 Jan;72:1-5 [PMID: 26519763]
  10. J Acquir Immune Defic Syndr. 2020 Nov 1;85(3):272-279 [PMID: 32740370]
  11. JAMA Netw Open. 2021 Aug 2;4(8):e2122692 [PMID: 34436609]
  12. AIDS Patient Care STDS. 2021 May;35(5):158-166 [PMID: 33901403]
  13. J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):349-55 [PMID: 19387357]
  14. J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):223-31 [PMID: 12794559]
  15. AIDS Behav. 2019 Jul;23(7):1951-1963 [PMID: 30565092]
  16. Addiction. 2007 Apr;102 Suppl 1:130-5 [PMID: 17493062]
  17. AIDS Behav. 2021 Apr;25(4):1210-1218 [PMID: 33185774]
  18. Curr HIV/AIDS Rep. 2022 Aug;19(4):235-250 [PMID: 35701713]
  19. AIDS Behav. 2021 Nov;25(11):3574-3604 [PMID: 33866444]
  20. Drug Alcohol Depend. 2021 Sep 1;226:108841 [PMID: 34271513]
  21. Drug Alcohol Depend. 2015 Jan 1;146:75-80 [PMID: 25482500]
  22. Front Public Health. 2016 Dec 19;4:275 [PMID: 28066754]
  23. Drug Alcohol Depend. 2012 Jun 1;123(1-3):79-83 [PMID: 22088656]
  24. J Subst Abuse Treat. 2002 Apr;22(3):149-56 [PMID: 12039618]
  25. Ann Fam Med. 2022 Mar-Apr;20(2):157-163 [PMID: 35045967]
  26. JAMA. 2019 Mar 5;321(9):844-845 [PMID: 30730529]
  27. Curr HIV/AIDS Rep. 2020 Dec;17(6):579-588 [PMID: 32965576]
  28. AIDS. 2006 Mar 21;20(5):731-9 [PMID: 16514304]
  29. Curr Med Res Opin. 2008 May;24(5):1345-57 [PMID: 18384709]
  30. J Health Soc Behav. 1995 Mar;36(1):38-56 [PMID: 7738327]
  31. J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219852122 [PMID: 31131664]
  32. AIDS. 2017 Mar 13;31(5):731-734 [PMID: 28060019]
  33. BMC Public Health. 2022 Mar 3;22(1):425 [PMID: 35241029]
  34. AIDS Care. 1996 Dec;8(6):655-69 [PMID: 8993716]
  35. J Acquir Immune Defic Syndr. 2020 Sep 1;85(1):23-29 [PMID: 32452970]
  36. J Homosex. 2001;41(2):17-35 [PMID: 11482426]
  37. BMC Public Health. 2018 Jul 25;18(1):914 [PMID: 30045702]
  38. Sex Transm Infect. 2017 Aug;93(5):342-346 [PMID: 28400466]
  39. Am J Mens Health. 2013 Mar;7(2):110-8 [PMID: 22948299]
  40. J Urban Health. 2020 Oct;97(5):679-691 [PMID: 31214977]
  41. AIDS Behav. 2018 May;22(5):1699-1712 [PMID: 28501965]
  42. Expert Rev Neurother. 2015;15(9):1005-14 [PMID: 26289485]
  43. J Urban Health. 2010 May;87(3):480-5 [PMID: 20101468]
  44. Drug Alcohol Depend. 2007 Jul 10;89(2-3):195-205 [PMID: 17257780]
  45. J Assoc Nurses AIDS Care. 2015 Sep-Oct;26(5):514-9 [PMID: 26279384]
  46. Drug Alcohol Depend. 2007 Oct 8;90(2-3):135-44 [PMID: 17398040]

Grants

  1. P30 AI050409/NIAID NIH HHS
  2. R34 DA046367/NIDA NIH HHS
  3. P30 MH133399/NIMH NIH HHS
  4. R00 DA041494/NIDA NIH HHS
  5. K99 DA041494/NIDA NIH HHS
  6. U54 MD002266/NIMHD NIH HHS
  7. P30 MH116867/NIMH NIH HHS
  8. R01 MH125727/NIMH NIH HHS

MeSH Term

Male
Humans
Young Adult
Adult
Middle Aged
Homosexuality, Male
Motivation
Florida
Poisons
Taste
Sexual and Gender Minorities
Central Nervous System Stimulants
Methamphetamine
HIV Infections

Chemicals

Poisons
Central Nervous System Stimulants
Methamphetamine

Word Cloud

Created with Highcharts 10.0.0usestimulantSMMHIVSouthFloridasexualminoritystimulantsmethmotivationsstigmamenqualitativestudylivingParticipantsparticipantsriskUS13experiencesfirstusingenvironmentalsoanticipatedduefactorsBACKGROUND:associated3-6timesgreaterrateseroconversionAnnuallyseroconvertwillpersistentmethamphetamineusersprimaryobjectiveexplorehighpriorityregionEndingEpidemicinitiativeMETHODS:sampleincluded25recruitedviatargetedadssocialnetworkingappscompletedone-on-onesemi-structuredinterviewsconductedJuly2019February2020generalinductiveapproachusedidentifythemesrelatingoverallrelationshipRESULTS:Meanage388ranging2061 yearsold44%White36%Latino16%Black4%Asianbornself-identifiedgaypreferredchoiceThemesincluded:cognitiveenhancementsfocustaskcompletionincludingtransitioningprescriptionpsychostimulants2uniqueopenregardingstatusinfluentialstigmatizingcopingmechanismfamilypotentialpartnersreportedcopefeelingsminoritizedidentitiesCONCLUSION:amongcharacterizeResultshighlightprotectivepsychostimulantmisuseinitiationroleUnderstandingcanhelpshapeinterventiondevelopmentincludesdevelopinginterventionsaddressindividualinterpersonalculturaldriveincreaseacquisitionTrialregistrationNCT04205487"Thefamiliartastepoison":multi-levelQualitativeresearchSexualStigmaStimulant

Similar Articles

Cited By